1. Antimicrobial proteins: intestinal guards to protect against liver disease

   • Tim Hendrikx
   • Bernd Schnabl

   Review Open access 03 November 2018 Pages: 209 - 217

   

2. Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science

   • Gurmehr Brar
   • Hidekazu Tsukamoto

   Review Open access 14 January 2019 Pages: 218 - 225

   

3. Helicobacter pylori status and risks of metachronous recurrence after endoscopic resection of early gastric cancer: a systematic review and meta-analysis

   • Shiyu Xiao
   • Sizhu Li
   • Jinzhe Liu

   Review 24 September 2018 Pages: 226 - 237

   

4. Development and validation of a web-based questionnaire to identify environmental risk factors for inflammatory bowel disease: the Groningen IBD Environmental Questionnaire (GIEQ)

   • Kimberley Wilhelmina Johanna van der Sloot
   • Rinse Karel Weersma
   • Behrooz Zaid Alizadeh

   Original Article—Alimentary Tract Open access 14 August 2018 Pages: 238 - 248

   

5. Capsule endoscopy findings for the diagnosis of Crohn’s disease: a nationwide case–control study

   • Motohiro Esaki
   • Takayuki Matsumoto
   • Yasuo Suzuki

   Original Article—Alimentary Tract Open access 15 September 2018 Pages: 249 - 260

   

6. The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin

   • Manuele Furnari
   • Alessandra De Alessandri
   • Rosaria Casciaro

   Original Article—Alimentary Tract 19 September 2018 Pages: 261 - 270

   

7. Clinical significance of hepatic steatosis according to coronary plaque morphology: assessment using controlled attenuation parameter

   • Hyo Eun Park
   • Heesun Lee
   • Goh Eun Chung

   Original Article—Liver, Pancreas, and Biliary Tract 04 October 2018 Pages: 271 - 280

8. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy

   • Yuko Suzuki
   • Motoyasu Kan
   • Masafumi Ikeda

   Original Article—Liver, Pancreas, and Biliary Tract Open access 08 October 2018 Pages: 281 - 290

   

9. Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures

   • Mitsutaka Osawa
   • Michio Imamura
   • Hiroshima Liver Study Group

   Original Article—Liver, Pancreas, and Biliary Tract 17 October 2018 Pages: 291 - 296

   

10. Sarcopenia definition in patients with NAFLD

    • Tao-Chun Peng

    Letter to the Editor 24 July 2018 Pages: 297 - 297

11. Reply to: Sarcopenia definition in patients with NAFLD

    • Yuya Seko

    Letter to the Editor 28 July 2018 Pages: 298 - 298

12. Long-awaited treatment for hepatitis C virus decompensated cirrhosis

    • Kiminori Kimura

    Editorial 01 January 2019 Pages: 299 - 300

13. Acknowledgements

    Acknowledgment 30 January 2019 Pages: 301 - 303